rethinkTHC Search
Menu
Study breakdown

Large epigenome study identified DNA methylation changes from cannabis use that are independent of cigarette smoking

ObservationalStrong evidence
The takeaway

A meta-analysis of 9,436 participants across seven cohorts and two ancestries identified four DNA methylation sites significantly associated with lifetime cannabis use after accounting for cigarette smoking effects.

Epigenetics and genomics researchers; biomarker scientists developing objective measures of cannabis exposure.

4 cannabis-specific DNA methylation sites identified across 9,436 participants

What the researchers found

Four CpG sites were significantly associated with lifetime cannabis use independent of smoking: cg22572071 (near ADGRF1), cg15280358 (in ADAM12), cg00813162 (in ACTN1), and cg01101459 (near LINC01132). In never-smokers, an additional site was found (cg14237301 in APOBR). A methylation score from these sites explained 3.79% of the variance in lifetime cannabis use.

Why it matters

Separating cannabis-specific epigenetic effects from smoking effects has been a major challenge. This large multi-ethnic study identifies methylation changes attributable to cannabis itself, which could serve as biomarkers and starting points for understanding how cannabis affects health at the molecular level.

The numbers in context

9,436 participants (7,795 European, 1,641 African ancestry). 4 significant CpG sites after FDR correction (p < 5.85 x 10^-7). 1 additional site in never-smokers. Methylation score explained 3.79% of variance in lifetime cannabis use.

How the study worked

Trans-ancestry epigenome-wide association study (EWAS) meta-analysis across seven cohorts including 7,795 European and 1,641 African ancestry participants. Analyses controlled for cigarette smoking effects. Leave-one-out approach for methylation score validation.

What this study cannot tell us

Peripheral blood methylation may not reflect brain or lung tissue changes. Binary outcome (ever vs never use) does not capture dose or frequency. Cross-sectional design cannot determine whether methylation changes are cause or consequence of use. 3.79% variance explained is modest.

How to read the evidence

Large multi-cohort meta-analysis with trans-ancestry replication and careful smoking adjustment. Strong methodology for epigenetic research.

When this study was published

2024 study

The bigger picture

These cannabis-specific DNA methylation changes could serve as objective biomarkers for cannabis exposure in research settings and may help explain biological pathways through which cannabis affects health outcomes differently from tobacco.

Questions still open

  • What biological functions do the identified genes (ADGRF1, ADAM12, ACTN1) serve, and could their methylation changes explain specific health outcomes? Do these methylation changes reverse after stopping cannabis use?

Common questions

What does DNA methylation mean for health?
DNA methylation is a chemical tag that can turn genes on or off without changing the DNA sequence. Changes in methylation from cannabis use could alter how genes function, potentially affecting health, though the specific consequences of these four sites are not yet known.
Could this be used as a drug test?
The methylation score explained only 3.79% of variance in cannabis use, making it far too imprecise for individual testing. It is more useful as a research tool to study population-level biological effects of cannabis.

Read the original research

Trans-ancestry epigenome-wide association meta-analysis of DNA methylation with lifetime cannabis use.

Molecular psychiatry, 29(1), 124-133

Citation

Fang, Fang; Quach, Bryan; Lawrence, Kaitlyn G; van Dongen, Jenny; Marks, Jesse A; Lundgren, Sara; Lin, Mingkuan; Odintsova, Veronika V; Costeira, Ricardo; Xu, Zongli; Zhou, Linran; Mandal, Meisha; Xia, Yujing; Vink, Jacqueline M; Bierut, Laura J; Ollikainen, Miina; Taylor, Jack A; Bell, Jordana T; Kaprio, Jaakko; Boomsma, Dorret I; Xu, Ke; Sandler, Dale P; Hancock, Dana B; Johnson, Eric O. (2024). Trans-ancestry epigenome-wide association meta-analysis of DNA methylation with lifetime cannabis use.. Molecular psychiatry, 29(1), 124-133. https://doi.org/10.1038/s41380-023-02310-w

Explore the wider topic